WRG-28 targets and inhibits discoidin domain receptors (DDRs), which are receptor tyrosine kinases involved in the regulation of cell growth, differentiation, and matrix remodeling. It targets DDR2.
Molecular Weight
410.44
Molecular Formula
C21H18N2O5S
Targets
DDR2: 230 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
WRG-28 serves as a DDR inhibitor for studies focused on inhibiting tumorigenic processes related to fibrosis and cancer metastasis.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
